Evaluating the effect of oral clarithromycin on acute cutaneous leishmaniasis lesions compared with systemic glucantime.

Zabolinejad, Naghmeh; Layegh, Pouran; Abbasi Shaye, Zahra; Salehi, Maryam; Ghanizadeh, Somayeh

Zabolinejad, Naghmeh; Layegh, Pouran; Abbasi Shaye, Zahra; Salehi, Maryam; Ghanizadeh, Somayeh.

Affiliation

Zabolinejad N; Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Layegh P; Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Abbasi Shaye Z; Clinical Research and Development Center of Akbar Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Salehi M; Department of Social Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Ghanizadeh S; Clinical Development Research Unit, Mashhad University of Medical Sciences, Mashhad, Iran.

J Dermatolog Treat ; 33(3): 1418-1423, 2022 May.

Article de En | MEDLINE | ID: mdl-32972289

Sujet(s)
Mots clés

Acute cutaneous leishmaniasis; oral clarithromycin; systematic glucantime

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Composés organométalliques / Leishmaniose cutanée / Antiprotozoaires Type d'étude: Risk_factors_studies Limites: Humans Langue: En Journal: J Dermatolog Treat Sujet du journal: DERMATOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: Iran Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google